Tower Research Capital »

Alnylam Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 9.6k 330.87
2025-12-31 $2.3M 5.8k 397.65
2025-09-30 $701k 1.5k 456.00
2025-06-30 $21k 64 326.09
2025-03-31 $367k 1.4k 265.10
2024-12-31 $1.3M 5.4k 235.31
2024-09-30 $149k 541 275.03
2024-06-30 $236k 973 243.00
2024-03-31 $259k 1.7k 149.45
2023-09-30 $901k 5.1k 177.10
2023-06-30 $1.8M 9.6k 189.94
2023-03-31 $135k 676 199.66
2022-12-31 $311k 1.3k 240.00
2022-09-30 $576k 2.9k 200.59
2022-06-30 $2.0M 14k 145.81
2022-03-31 $2.3M 14k 163.31
2021-12-31 $1.1M 6.7k 169.66
2021-09-30 $169k 896 188.62
2021-06-30 $352k 2.1k 169.39
2021-03-31 $184k 1.3k 142.86
2020-12-31 $1.1M 8.2k 130.86
2020-09-30 $631k 4.3k 145.75
2020-06-30 $213k 1.4k 148.23
2020-03-31 $3.0k 25 120.00
2019-12-31 $181k 1.6k 115.29
2019-06-30 $59k 828 71.43
2019-03-31 $14k 152 92.11
2018-09-30 $113k 1.3k 87.20
2018-06-30 $15k 149 100.67
2018-03-31 $663k 5.6k 119.05
2016-12-31 $61k 1.6k 37.26
2016-09-30 $57k 842 67.70
2016-03-31 $3.0k 40 75.00
2015-12-31 $28k 302 92.72
2015-06-30 $47k 389 120.82
2015-03-31 $24k 227 105.73
2014-12-31 $45k 467 96.36
2014-09-30 $38k 483 78.67
2014-06-30 $79k 1.2k 63.40
2014-03-31 $165k 2.4k 67.51
2013-12-31 $32k 490 65.31
2013-09-30 $340k 5.3k 64.09
2013-06-30 $23k 729 31.55